tiprankstipranks
Kintara Postpones Stockholder Meeting for Merger Decision
Company Announcements

Kintara Postpones Stockholder Meeting for Merger Decision

Story Highlights

Kintara Therapeutics (KTRA) has released an update.

Don't Miss Our Christmas Offers:

Kintara Therapeutics has postponed its Special Meeting of Stockholders to October 4, 2024, due to insufficient votes on key proposals related to a charter amendment and a strategic merger with TuHURA Biosciences. The adjournment aims to facilitate decisions on increasing Kintara’s authorized shares and the planned merger, which could bolster its solid tumor cancer therapy development.

For further insights into KTRA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyKintara Therapeutics Inc trading halted, news pending
TipRanks Canadian Auto-Generated NewsdeskKintara Therapeutics Announces Stock Split Amid Merger
TheFlyKintara announces 1-for-35 reverse stock split in connection with TuHURA merger
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App